Loading...
Loading...
Ping An Biomedical Co., Ltd.
Ping An Biomedical Co., Ltd.. Spoken Alpha tracks PASW's earnings calls, guidance changes, and executive accountability over time.
Spoken Alpha tracks PASW's historical accountability: how often management beat consensus, how the stock reacted, and how guidance evolved across the cycle. The figures below are illustrative placeholder data generated for layout — they will be replaced with real deviation metrics, True Consensus values, and EODHD price reactions as those data layers land.
Beats consensus 5/10 quarters with 60% positive reaction rate
SampleConsistent execution against consensus with the stock following through is the cleanest signal a guidance regime is calibrated. Worth watching for the inflection where execution deteriorates relative to the bar.
Missed in 2 of the last 4 quarters
SampleRecent misses matter more than long-window beat rate — the trailing 12 months drives the analyst model and the next-print bar.
The same data on this page is available as a machine-readable feed via the Spoken Alpha API. One call returns the IR URL, recent transcripts, and accountability scores for PASW.
curl https://api.spokenalpha.com/v1/companies/PASW| Quarter | Actual EPS | Consensus | Surprise | 1D | 5D |
|---|---|---|---|---|---|
| Q1 FY2026 | $1.96 | $1.94 | +0.8% | -4.8% | -5.6% |
| Q4 FY2026 | $2.05 | $2.12 | -3.4% | +4.0% | +2.0% |
| Q3 FY2026 | $1.97 | $1.96 | +0.5% | -0.1% | +2.3% |
| Q2 FY2026 | $1.83 | $1.89 | -3.3% | -4.7% | -4.3% |
| Q1 FY2025 | $2.11 | $2.16 | -2.1% | +1.1% | +1.1% |
| Q4 FY2025 | $2.09 | $2.22 | -5.7% | +3.0% | +4.6% |
| Q3 FY2025 | $2.24 | $2.20 | +1.7% | +1.2% | +0.1% |
| Q2 FY2025 | $2.37 | $2.24 | +6.0% | -0.9% | -2.3% |
| Q1 FY2024 | $2.18 | $2.26 | -3.5% | +3.3% | +5.9% |
| Q4 FY2024 | $2.33 | $2.28 | +2.1% | +4.6% | +5.3% |